Skip to Content

C223 (Alendronate Sodium 35 mg)

Pill with imprint C223 is White, Capsule-shape and has been identified as Alendronate Sodium 35 mg. It is supplied by Cipla USA Inc..

Alendronate is used in the treatment of osteoporosis; prevention of osteoporosis; paget's disease; aseptic necrosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Alendronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C223

Alendronate sodium 35 mg C223

Alendronate Sodium

Imprint:
C223
Strength:
35 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Bisphosphonates
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Cipla USA Inc.
National Drug Code (NDC):
69097-0223

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide